Skip to content

caridel

Active Private limited companyfounded 2003active for 23 yearsRue des Badauds 21, 1428 Braine-l'AlleudKBO/BCE: BE 0860.350.903

Lifetime

17 annual accounts with figures on one time axis, 22 filings since 2004
peak of €184,703 in 2025
€184,703▲ 34.1%
peak of €130,251 in 2025
€130,251▲ 31.4%
peak of €599,662 in 2025
€599,662▲ 27.7%
€64,435▼ 21.5%
Board1 name since 2022
1 director
Documentsfilings and deeds
28-01-20263 days before the deadline
2025micro format
Gross margin from €137,758 to €184,703Result from €99,141 to €130,251Equity from €469,412 to €599,662Debts from €82,132 to €64,435Cash from €203,235 to €71,094

Key points

from the 2025 annual accounts

Equity

€599,662 ▲ 27.7%

caridel has made a profit in every financial year since 2009.

Filings

22 annual accounts since 2004
deadline20102020

Three of the last ten came late. The 2017 accounts came in latest, 26 days after the end of the period.

Position in the sector

€599,662

More equity than 85% of companies in human health. The sector median is €125,219, over 21,370 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as caridel has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for caridel. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 09-01-2014
Board & ownership

Recent changes

changes role from manager to director Legal-form conversion: from private limited company (pre-2019) to private limited company · Discharge granted to · General meeting of 07-04-2023 · Gazette deed
Capital decrease of €271,800 to €18,600 The capital fell from €290,400 to €18,600 · General meeting of 09-03-2018 · Gazette deed
Capital increase of €271,800 to €290,400 The capital rose from €18,600 to €290,400, with 1,461 new shares · holds 100 shares · General meeting of 19-12-2013 · Gazette deed
Incorporation published on 11-09-2003 · Gazette deed
All 32 events

Comparable companies

same main activity, similar in size and age
Company
caridel Braine-l'Alleud €664,097 €184,703 90.3% -
OPHTALMOLOGIE LIMBOURG Tubize €595,626 €185,565 55.3% -
MA-EL RX Braine-l'Alleud €575,579 €187,193 87.8% 0.2
DOKTER JELTSJE TACK Tongeren-Borgloon €682,043 €180,191 67.0% -
DR. VAN MELLAERT C Antwerp €641,052 €190,887 95.8% -
Bie Schoolmeesters Herent €627,992 €191,289 85.4% -
Docteur Simonet Olivier Brunehaut €652,084 €196,915 87.4% -

These companies have the same main activity as caridel: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €576,000 and €682,000, founded between 2003 and 2004.

Official details

Source: KBO
Status
Active since 30-09-2003Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.253.631.8801428 Braine-l'Alleud, since 30-09-2003
Financial year end
30 June
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 30-06-2025

≈ €340,000estimated
€664,097▲ 20.4%
Filing
Filed on 28-01-2026, 3 days before the end of the filing period
Financials

Insights on caridel

caridel files the micro format. That format states no turnover. The gross margin rose from €120,587 in 2009 to €184,703 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about caridel

What is the company number of caridel?
The company number of caridel is 0860.350.903. The VAT number is the same number with BE in front: BE 0860.350.903.
Where is caridel based?
The registered office is at Rue des Badauds 21, 1428 Braine-l'Alleud.Company details
What does caridel do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of caridel?
caridel is a private limited company (BV).
When was caridel founded?
caridel was founded on 30-09-2003.
Is caridel still active?
Yes, caridel is an active enterprise in the KBO register.
What is the turnover of caridel?
The turnover in financial year 2025 is about €340,000. This figure is estimated from the gross margin of €184,703 and 40 comparable companies (NACE 86220). It probably lies between €290,000 and €460,000.Financials
Is caridel profitable?
In financial year 2025, caridel made a profit of €130,251.
Where can I find the annual accounts of caridel?
caridel filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of caridel due?
caridel must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.